• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Friday, March 24, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Tata Motors Rating ‘Reduce’; JLR results beat consensus estimates

by The Outlooker Web Desk
February 6, 2021
in Business
0
Tata Motors Rating ‘Reduce’; JLR results beat consensus estimates
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Q3FY21 FCF at Rs 79 bn (JLR: GBP562 mn, India: Rs 22 bn) was helped by working capital reversals (GBP264mn+Rs 22 bn).

JLR’s Q3FY21 adj Ebitda at GBP855 mn (14.4% margin) was broadly in line with our estimate of GBP885 mn (14.3% margin). Margins were up by GBP55 mn/ GBP36 mn reversal of provision/residual value. We had expected results to beat consensus due to strong Land Rover mix. For India, Ebitda margin at 5.8% (Nom: 6.2%) was also in line. Q3FY21 FCF at Rs 79 bn (JLR: GBP562 mn, India: Rs 22 bn) was helped by working capital reversals (GBP264mn+Rs 22 bn). CV/PV Ebitda margins were at 8%/3.8%.

Commentary: India: CV business momentum is improving. In PVs, TTMT plans to achieve double-digit market share with the launch of Safari and Hornbill. Material cost increases will come through in Q4FY21F. JLR: Q4FY21F margins could be lower than Q3FY21 as the mix of Jaguar normalises, in our view. JLR will continue to operate at 4% + Ebit margins and remain FCF-positive.

India: Given our view on the CV cycle, we raise our Medium, Heavy Commercial Vehicle (MHCV) growth estimates to +80/+25/+15% (up 20/7/7%) over FY22-24F) and Ebitda margins at 6.1/8.0/8.2% (vs 5.9/7.5/7.7%). We also raise PV volumes to 320k/354k vs 213k/234k over FY22-23F. Overall, we raise Ebitda estimates by 21-22%.

JLR: We revise our volume estimates to 435k/577k/604k over FY21-23F (vs 477k/536k/ 594k), as we expect a stronger rebound in FY22F post a weaker FY21F. Global car supply is expected to remain tight in the near term and JLR inventories are lean. Hence, we raise our Ebitda margins by 150bp/60bp to 14% /14% over FY22-23F, leading to 28%/11% higher Ebitda.

Valuation: higher SOTP-based target price of Rs 244
With higher Ebitda assumptions, we expect net auto debt to reduce to ~Rs 290 bn by FY23F (vs Rs 535 bn earlier). With improved debt position and improvement for luxury peer multiples, we now value JLR at 1.75x FY23F EV/Ebitda (1.5x earlier). We value domestic business at 8x FY24F Ebitda discounted back to FY23F and subs at Rs 71/sh. The stock is trading at 3x FY23F EV-Ebitda, which is expensive, in our view.

We remain concerned about competition’s battery EV pipeline and investments in autonomous driving where JLR lags. While short term margins may remain strong, we believe margins have peaked. Any rise in competition can impact earnings sharply. We prefer MM (MM IN, Buy) and AL (AL IN, Buy) in the OEM space.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
India Working On 7 More COVID-19 Vaccines, Says Health Minister

India Working On 7 More COVID-19 Vaccines, Says Health Minister

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
National

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

March 24, 2023
Vandalism At Indian High Commission In London Raised In UK Parliament
National

Vandalism At Indian High Commission In London Raised In UK Parliament

March 23, 2023
Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points
National

Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

March 23, 2023
Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation
National

Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation

March 23, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
  • Vandalism At Indian High Commission In London Raised In UK Parliament
  • Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.